ArticleFrontiers in pharmacology2022

Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease.

Fu-Shun Yen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.